Global Electronic Drug Delivery Systems Market Size 2024, Forecast To 2033

The electronic drug delivery systems market has exhibited robust growth, growing from $10.54 billion in 2023 to $11.45 billion in 2024, showcasing a notable compound annual growth rate (CAGR) of 8.6%. The growth in the historic period is attributed to factors such as the increased incidence of chronic diseases, an aging population, patient preferences for non-invasive delivery methods, healthcare cost containment efforts, and advancements and validation in clinical applications. Moving forward, the electronic drug delivery systems market is expected to maintain strong growth, reaching $16.12 billion in 2028 at a CAGR of 8.9%. The anticipated growth in the forecast period is associated with factors including the growing trend towards drug personalization, a rise in global healthcare expenditure, the adoption of a patient-centric healthcare approach, the emergence of targeted therapies, a supportive regulatory environment, and ongoing advancements in remote patient monitoring. Noteworthy trends for 2028 encompass the incorporation of artificial intelligence (AI), the use of biocompatible materials and implantable devices, customization for specific therapeutic areas, regulatory advancements and standardization, and collaborations between pharmaceutical and technology companies.